ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,090Medicare Part D Prescriptions Filled, Including Refills

Rank: 198 out of 1942

$384K Total Retail Price of All Prescriptions

Rank: 250 out of 1942

363 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 363 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 363 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 6,604 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 465 360 1 1
LISINOPRIL 362 293 2 2
LEVOTHYROXINE SODIUM 317 266 3 3
OMEPRAZOLE 276 223 4 4
METOPROLOL SUCCINATE 226 200 5 13
AMLODIPINE BESYLATE 213 157 6 6
METOPROLOL TARTRATE 206 198 7 9
FUROSEMIDE 203 179 8 5
HYDROCHLOROTHIAZIDE 180 134 9 8
RAMIPRIL 157 142 10 111
METFORMIN HCL 151 109 11 10
ALENDRONATE SODIUM 140 119 12 21
HYDROCODONE-ACETAMINOPHEN 138 103 S3 13 12
WARFARIN SODIUM 132 125 14 11
GLIMEPIRIDE 130 115 15 53
SERTRALINE HCL 118 96 16 20
CRESTOR 117 102 17 34
GABAPENTIN 100 79 18 16
DONEPEZIL HCL 99 88 19 30
SPIRIVA 99 88 19 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 93 21 22
ATORVASTATIN CALCIUM 95 84 22 14
TAMSULOSIN HCL 93 91 23 29
TRAMADOL HCL 89 52 24 19
ATENOLOL 85 70 25 7
ISOSORBIDE MONONITRATE ER 74 74 26 42
DIOVAN 72 52 27 44
MELOXICAM 70 52 28 81
POLYETHYLENE GLYCOL 3350 69 56 29 28
FENOFIBRATE 68 53 30 82
POTASSIUM CHLORIDE 66 53 31 17
MIRTAZAPINE 64 39 32 38
TERAZOSIN HCL 63 42 33 77
LOSARTAN POTASSIUM 63 59 33 18
GLYBURIDE 60 54 R 35 69
NAMENDA 55 48 36 51
FLUOXETINE HCL 53 41 37 45
VENLAFAXINE HCL ER 53 27 37 70
CITALOPRAM HBR 52 47 39 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.